Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Cardiovascular Drug Access in Australia and New Zealand: New PBS and PHARMAC Listings, 2023-2025.

Heart, lung & circulation·2026
Same author

Optimising Cardiovascular Care Delivery With Precision and Equity.

Heart, lung & circulation·2026
Same author

Evolving landscape of drug development for pediatric rare diseases-from successes to strategies for addressing unmet needs.

Journal of pharmaceutical sciences·2026
Same author

Extracorporeal Membrane Oxygenation in the Interstage Period After Norwood and Related Stage I Palliations in Infants With Single Ventricle: A Systematic Review of Incidence, Risk Factors, and Outcomes.

Journal of the American Heart Association·2026
Same author

Progress in cell therapies for neonatal conditions: Proceedings of the Third Neonatal Cell Therapies Symposium (2025).

Pediatric research·2026
Same author

Telehealth's Equity Test in Cardiovascular Care: Can We Build What We've Designed?

Heart, lung & circulation·2026
Same journal

Initial 4-Year Experience with Microaxial Flow Pumps within a Tertiary Centre in Regional Australia.

Heart, lung & circulation·2026
Same journal

Health Care Workers' Preferences in the Delivery of Atrial Fibrillation Screening: A Systematic Review.

Heart, lung & circulation·2026
Same journal

Meta-Analysis of Randomised Controlled Trials on the Efficacy of Direct Oral Anticoagulants in Left Ventricular Thrombosis: An Updated Perspective.

Heart, lung & circulation·2026
Same journal

Letter to the Editor "Constructive Critique on CKM Implementation: Focusing on Non-Pharmacological Burden and Staging Utility" regarding: "Implementation Barriers to Evidence-Based Cardiovascular-Kidney-Metabolic Syndrome Management" by Davis et al. Heart Lung Circ. 2025;34:1060-1068.

Heart, lung & circulation·2026
Same journal

Reply to Letter to the Editor "Interpreting Biomarker Changes after Mechanical Thrombectomy in Intermediate-High Risk Pulmonary Embolism".

Heart, lung & circulation·2026
See all related articles

Related Experiment Video

Updated: May 11, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Bridging the Gap Between Machine Learning Innovation and Clinical Practice

Salvatore Pepe1

  • 1Editor-in-Chief, Heart Lung and Circulation, Sydney, NSW, Australia; Murdoch Children's Research Institute, Heart Research Group and Department of Paediatrics, The University of Melbourne, Royal Children's Hospital Melbourne, Vic, Australia.

Heart, Lung & Circulation
|May 9, 2026
PubMed
Summary

No abstract available in PubMed .

Keywords:
Artificial intelligenceCardiologyCardiovascular riskMachine learning

Related Experiment Videos

Last Updated: May 11, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025